AU Patent

AU2011255630B2 — Treatment of Clostridium difficile infection in patients undergoing antibiotic therapy

Assigned to Merck Sharp and Dohme LLC · Expires 2015-04-30 · 11y expired

What this patent protects

The present invention relates to methods of treating Clostridium difficile infection in a subject receiving antibiotic therapy for a different infection comprising administering to the subject an effective amount of the compounds described herein.

USPTO Abstract

The present invention relates to methods of treating Clostridium difficile infection in a subject receiving antibiotic therapy for a different infection comprising administering to the subject an effective amount of the compounds described herein.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011255630B2
Jurisdiction
AU
Classification
—
Expires
2015-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.